SymBio Pharmaceuticals Limited (TYO:4582)
Japan · Delayed Price · Currency is JPY 57.00
-1.00 (-1.72%)
Sep 11, 2026, 3:30 PM JST
SymBio Pharmaceuticals Market Cap
SymBio Pharmaceuticals has a market cap or net worth of 4.57 billion as of September 11, 2026. Its market cap has decreased by -34.94% in one year.
Market Cap
4.57B
Enterprise Value
4.42B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
57.00
ChartMarket Cap Chart
Since October 20, 2011, SymBio Pharmaceuticals's market cap has decreased from 7.08B to 4.57B, a decrease of -35.45%. That is a compound annual growth rate of -2.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.57B | -9.06% |
| Dec 30, 2025 | 5.02B | -44.92% |
| Dec 30, 2024 | 9.12B | -12.48% |
| Dec 29, 2023 | 10.42B | -58.97% |
| Dec 30, 2022 | 25.40B | -42.20% |
| Dec 30, 2021 | 43.94B | 203.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cawachi | 83.20B |
| YAKUODO HOLDINGS | 31.92B |
| Astena Holdings | 20.82B |
| Satudora Holdings | 17.21B |
| Renascience | 16.74B |
| Medical System Network | 14.26B |
| Ohki Healthcare Holdings | 13.64B |
| Pharmarise Holdings | 5.83B |